20 Aug
Companies Ink Deal for Oral Cancer Detection Products
Companies Ink Deal for Oral Cancer Detection Products August 20, 2015 Vigilant Biosciences has struck a three-year deal with Crown Dental + Medical Limited to distribute the OncAlert Oral Cancer Risk Assessment System in New Zealand. The product includes the OncAlert Oral Cancer Rapid Point-of-Care Risk Assessment Test (OncAlert POC Test) and OncAlert Oral Cancer
Vigilant Biosciences Announces Agreement with Crown Dental + Medical Limited for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in New Zealand
Vigilant Biosciences Announces Agreement with Crown Dental + Medical Limited for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in New Zealand August 18, 2015 AUCKLAND, New Zealand and FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced
Recent Posts
Recent Comments